In up to 15% of nephroblastoma cases, commonly known as the Wilms tumor (WT), malignant development is associated with germline mutations in cancer risk genes, such as single nucleotide variants or deletion of the WT1 gene, and some cancer predisposition syndromes [2]. This evidence concerns the gene WT1 and Nephroblastoma.